drug
risperidone PR
Marketedupdated 3mo agoby Johnson & Johnson Innovative Medicine
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5all catalysts(0)
nothing on the calendar yet
Trials studying risperidone PR
- phase3Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications
- phase4An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment
- —Long-term Antipsychotic Pediatric Safety Trial
- phase2Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)
- phase3Long-Term Study of MP-214 in Patients With Schizophrenia
- phase3Safety and Efficacy of MP-214 in Patients With Schizophrenia
- phase3A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
- —Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that